GlaxoSmithKline Spin-Off to Create Healthcare Giant Worth Estimated £40 Bil

...2017, has described the demerger as the group’s most significant corporate change in 20 years. The split sees GSK “parcelling off a considerable quantity of its sizable debt pile into Haleon, expected to be around £10 bi...
Read Full Article